Limited Use Note(s) |
|
BRINZOLAMIDE & BRIMONIDINE TARTRATE1.0% & 0.2% Oph Susp-10mL Pk
| Reason For Use Code | Clinical Criteria |
|---|---|
| 466 | As second-line therapy for patients who do not have an adequate intraocular pressure lowering response to monotherapy with brinzolamide or brimonidine. |
| LU Authorization Period: Indefinite. | |
| 393 | For use as initial therapy in an urgent situation (e.g. patients with a high baseline intraocular pressure) where monotherapy is unlikely to be effective. |
| LU Authorization Period: Indefinite. |